FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 83 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,036,909 | +550.9% | 233,538 | +317.8% | 0.00% | – |
| Q1 2023 | $159,315 | -48.9% | 55,900 | +30.6% | 0.00% | – |
| Q4 2022 | $311,584 | +2.5% | 42,800 | +13.8% | 0.00% | – |
| Q3 2022 | $304,000 | +85.4% | 37,600 | +12.2% | 0.00% | – |
| Q2 2022 | $164,000 | -67.9% | 33,500 | +55.1% | 0.00% | – |
| Q1 2022 | $511,000 | +33.8% | 21,600 | 0.0% | 0.00% | – |
| Q4 2021 | $382,000 | -18.4% | 21,600 | +30.1% | 0.00% | – |
| Q3 2021 | $468,000 | +169.0% | 16,600 | 0.0% | 0.00% | – |
| Q2 2021 | $174,000 | -5.9% | 16,600 | +5.7% | 0.00% | – |
| Q1 2021 | $185,000 | +0.5% | 15,700 | 0.0% | 0.00% | – |
| Q4 2020 | $184,000 | +47.2% | 15,700 | 0.0% | 0.00% | – |
| Q3 2020 | $125,000 | -54.4% | 15,700 | +4.7% | 0.00% | – |
| Q2 2020 | $274,000 | -91.9% | 15,000 | -97.1% | 0.00% | -100.0% |
| Q3 2019 | $3,382,000 | – | 509,369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |